Fulltext

Severe Mycoplasma hominis Infections in Two Renal Transplant Patients

Rohner, P. ; Schnyder, I. ; Ninet, B. ; Schrenzel, J. ; Lew, D. ; Ramla, T. ; Garbino, J. ; Jacomo, V.

In: European Journal of Clinical Microbiology and Infectious Diseases, 2004, vol. 23, no. 3, p. 203-204

Add to personal list
    Title
    • Severe Mycoplasma hominis Infections in Two Renal Transplant Patients
    Author
    • Rohner, P.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    • Schnyder, I.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    • Ninet, B.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    • Schrenzel, J.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    • Lew, D.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    • Ramla, T.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    • Garbino, J.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    • Jacomo, V.. Service des Maladies Infectieuses, Hôpitaux Universitaire de Genève, 1211, Genève 14, Switzerland
    Document Type
    • Postprint
    Language
    • English
    Published in
    • European Journal of Clinical Microbiology and Infectious Diseases, 2004, vol. 23, no. 3, p. 203-204. Springer-Verlag
    Other Version
    Classification
    • Health
    OAI-PMH Identifier
    • oai:doc.rero.ch:322514
    Summary
    Systemic infections due to Mycoplasma hominis are rare and occur mainly in immunocompromised patients. Reported here are the cases of two renal transplant patients with peritonitis who did not respond to empirical antimicrobial treatment. Effective treatment with doxycycline was administered only after definitive identification of Mycoplasma hominis was achieved. For this identification, the new genetic amplification-sequencing method was invaluable